Hormonal
Ketogenic diets may offer unique metabolic benefits for cancer and neurodegenerative diseases through mechanisms like the Warburg effect and ketone utilization by the brain.
For individuals with cancer or neurodegenerative diseases like Alzheimer's, a ketogenic diet may offer metabolic benefits by targeting underlying insulin resistance and mitochondrial dysfunction. It is not a cure but may act synergistically with other treatments. Consult a healthcare provider before starting, as research is ongoing.
Chronic ketosis might confer unique metabolic benefits of relevance to cancer, neurodegenerative conditions, and other diseases associated with insulin resistance.
Why this rating
The paper cites 'preliminary reports', 'ancillary treatment', and 'planned or active trials', indicating a lack of large-scale conclusive evidence.
Source
The Ketogenic Diet: Evidence for Optimism but High-Quality Research Needed
David S. Ludwig · Journal of Nutrition · 2019
DOI 10.1093/jn/nxz308
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →